These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 20856127

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T.
    Attenberger UI, Runge VM, Morelli JN, Williams J, Jackson CB, Michaely HJ.
    J Magn Reson Imaging; 2010 Mar; 31(3):549-55. PubMed ID: 20187196
    [Abstract] [Full Text] [Related]

  • 4. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P, Runge VM, Bücker A, Schürholz H, Reith W, Robert P, Jackson C, Lanz T, Schneider G.
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [Abstract] [Full Text] [Related]

  • 5. Brain tumor enhancement in MR imaging at 3 Tesla: comparison of SNR and CNR gain using TSE and GRE techniques.
    Wintersperger BJ, Runge VM, Biswas J, Reiser MF, Schoenberg SO.
    Invest Radiol; 2007 Aug; 42(8):558-63. PubMed ID: 17620938
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dynamic contrast enhancement of experimental glioma an intra-individual comparative study to assess the optimal time delay.
    Engelhorn T, Schwarz MA, Eyupoglu IY, Kloska SP, Struffert T, Doerfler A.
    Acad Radiol; 2010 Feb; 17(2):188-93. PubMed ID: 19910218
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Gd-DTPA-induced signal enhancements in rat brain C6 glioma among different pulse sequences in 3-Tesla magnetic resonance imaging.
    Sato H, Enmi J, Teramoto N, Hayashi T, Yamamoto A, Tsuji T, Naito H, Iida H.
    Acta Radiol; 2008 Mar; 49(2):172-9. PubMed ID: 18300142
    [Abstract] [Full Text] [Related]

  • 11. [Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study].
    Vogl TJ, Friebe CE, Balzer T, Mack MG, Steiner S, Schedel H, Pegios W, Lanksch W, Banzer D, Felix R.
    Radiologe; 1995 Aug; 35(8):508-16. PubMed ID: 7568795
    [Abstract] [Full Text] [Related]

  • 12. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
    Huang B, Liang CH, Liu HJ, Wang GY, Zhang SX.
    Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases.
    Fan B, Li M, Wang X, Xu Y, Li F, Zhang L, Jiang J, Jiang Y.
    J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616
    [Abstract] [Full Text] [Related]

  • 14. Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine.
    Durmus T, Schilling R, Doeblin P, Huppertz A, Hamm B, Taupitz M, Wagner M.
    Invest Radiol; 2012 Mar; 47(3):183-8. PubMed ID: 22183078
    [Abstract] [Full Text] [Related]

  • 15. Brain tumor enhancement in magnetic resonance imaging: dependency on the level of protein binding of applied contrast agents.
    Wintersperger BJ, Runge VM, Tweedle MF, Jackson CB, Reiser MF.
    Invest Radiol; 2009 Feb; 44(2):89-94. PubMed ID: 19077910
    [Abstract] [Full Text] [Related]

  • 16. Enhancement in a brain glioma model: a comparison of half-dose gadobenate dimeglumine versus full-dose gadopentetate dimeglumine at 1.5 and 3 T.
    Morelli JN, Gerdes CM, Zhang W, Williams JM, Saettele MR, Ai F.
    J Magn Reson Imaging; 2013 Aug; 38(2):306-11. PubMed ID: 23737259
    [Abstract] [Full Text] [Related]

  • 17. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M, Tartaro A, Tartaglione T, Pirovano G, Kirchin MA, Spinazzi A.
    Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
    [Abstract] [Full Text] [Related]

  • 18. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J, Sammet S, Yang X, Jia G, Takayama Y, Knopp MV.
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [Abstract] [Full Text] [Related]

  • 19. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
    Giesel FL, Mehndiratta A, Risse F, Rius M, Zechmann CM, von Tengg-Kobligk H, Gerigk L, Kauczor HU, Politi M, Essig M, Griffiths PD, Wilkinson ID.
    Acta Radiol; 2009 Jun; 50(5):521-30. PubMed ID: 19337867
    [Abstract] [Full Text] [Related]

  • 20. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
    Katakami N, Inaba Y, Sugata S, Tsurusaki M, Itoh T, Machida T, Tanaka H, Nakayama T, Morikawa T, Breuer J, Aitoku Y.
    Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.